Forest Laboratories Inc. agreed to buy specialty pharmaceutical company Aptalis Holdings Inc. for $2.9 billion in cash.
Private-equity firm TPG purchased Aptalis, at the time called Axcan Pharma Inc., in 2008 for about $1.3 billion. Axcan later merged with Eurand NV to create a company that was renamed Aptalis.